Trailing-twelve-month (TTM) revenue is $53.66 Million with a year-over-year growth of (70.13%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,620,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $3,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-10 |
| Q1 FY2026Period ended 2026-03-31 | $6,242,580 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $41,002,253 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $53,664,833 |
Current P/S: $234,537,797 market capitalization ÷ $53,664,833 TTM revenue = 4.37x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:05:16.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $41.00M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:09:38.827Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product Sales and Supportive Services | $469M | $11M | $87M | $131M | $133M | $88M |
| Research and Development | $8M | $16M | $24M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Asia Pacific | $15M | $966,633 | $14M | N/A |
| CANADA | $39M | N/A | $737,677 | $6M |
| EMEA | $16M | $20M | $8M | N/A |
$53.66M
$53.66 Million
(70.13%)
vs. $179.66M a year ago (TTM)
(10.88%)
5 Year compound annual growth rate
1 Year
(70.13%)
3 Year
+17.07%
5 Year
(10.88%)
10 Year
+19.98%
15 Year
+9.43%
20 Year
+9.98%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $94.60M | ($44.12M) | (31.80%) |
| 2024 | $138.72M | ($1.20M) | (0.86%) |
| 2023 | $139.92M | +$29.14M | +26.31% |
| 2022 | $110.78M | ($22.89M) | (17.13%) |
| 2021 | $133.67M | +$8.71M | +6.97% |
| 2020 |
TTM Growth
(70.13%)
3-Year CAGR
+17.07%
5-Year CAGR
(10.88%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:09:38.827Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $5M |
| $7M |
| Non-US | $71M | $21M | $23M | $6M |
|---|
| Other | $972,799 | N/A | N/A | N/A |
|---|
| UNITED STATES | $40M | $119M | $116M | $89M |
|---|
| $124.96M |
| +$98.22M |
| +367.28% |
| 2019 | $26.74M | ($450.31M) | (94.39%) |
| 2018 | $477.05M | +$464.78M | +3788.30% |
| 2017 | $12.27M | ($2.72M) | (18.14%) |
| 2016 | $14.99M | +$6.81M | +83.32% |
